SCHEMBL744989

SCHEMBL744989

O=S(=O)(c1ccccc1Cl)N1CCC2(CCCN(c3ccc(C(F)(F)F)cc3)C2)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 13/20 0.57
CYP2C9 P11712 9/20 0.57
CYP2C19 P33261 8/20 0.57
TSHR P16473 8/20 0.57
CYP2D6 P10635 7/20 0.57
CYP1A2 P05177 7/20 0.57
ALDH1A1 P00352 7/20 0.57
SMN1; SMN2 Q16637 4/20 0.54
USP2 O75604 5/20 0.47
HIF1A Q16665 4/20 0.47
MAPK1 P28482 3/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
HSD17B10 Q99714 2/20 0.47
LIPE Q05469 1/20 0.47
TP53 P04637 1/20 0.46
MDM2 Q00987 1/20 0.46
CHRM4 P08173 1/20 0.46
ATM Q13315 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL744430 0.81 LIPE (0.68) CYP3A4CYP2C9CYP2C19TSHRCYP2D6
SCHEMBL744218 0.79 CYP3A4 (0.52) CYP3A4CYP2C9CYP2C19TSHRCYP2D6
SCHEMBL744232 0.79 LIPE (0.68) TSHRALDH1A1MEN1KMT2ALIPE
SCHEMBL745542 0.78 CYP2C9 (0.52) CYP3A4CYP2C9CYP2C19TSHRCYP2D6
SCHEMBL746534 0.77 CYP3A4 (0.48) CYP3A4CYP2C9CYP2C19TSHRCYP2D6
SCHEMBL3753670 0.77 LIPE (0.75) TSHRALDH1A1MEN1KMT2ALIPE
SCHEMBL746711 0.77 CYP2C9 (0.48) CYP3A4CYP2C9CYP2C19TSHRCYP2D6
SCHEMBL744705 0.75 CYP1A2 (0.47) CYP3A4CYP2C9CYP2C19TSHRCYP2D6
SCHEMBL746672 0.72 CYP3A4 (0.73) CYP3A4CYP2C9CYP2C19TSHRCYP2D6
SCHEMBL746622 0.72 CCR1 (0.44) CYP3A4CYP2C9CYP2C19TSHRCYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2430023-A1 AZACYCLIC SPIRODERIVATIVES AS HSL INHIBITORS F. Hoffmann-La Roche AG (CH) 2012-03-21 EP disclosed
WO-2010130665-A1 AZACYCLIC SPIRODERIVATIVES AS HSL INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2010-11-18 WO disclosed